ClinConnect ClinConnect Logo
Search / Trial NCT06314594

The Individualized Stepwise Treatment Mode of Adolescent Idiopathic Scoliosis

Launched by HANGZHOU MEDICAL COLLEGE · Mar 11, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to treat adolescent scoliosis, a condition where the spine curves abnormally in young people. The researchers are using advanced techniques to create a model that helps identify which teens may need treatment and how to provide the best care for them. They aim to develop a step-by-step treatment plan based on individual needs and conduct an analysis of the costs involved.

To participate in the trial, young people aged 12 to 16 with mild to moderate scoliosis (with a spine curve of less than 45 degrees) are welcome. It's important that they have no history of serious mental health issues and can communicate well. Participants will work closely with the research team, and their families will need to provide consent for them to join. This trial is currently recruiting, so if you or someone you know fits the eligibility criteria and is interested in helping advance scoliosis treatment, this could be a great opportunity.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. The diagnosis of moderate and mild AIS, with a Cobb angle measuring less than 45°;
  • 2. The age range of 12 to 16 years old;
  • 3. Participants are required to have no history of mental illness, possess normal communication skills, and be proficient in reading and writing;
  • 4. Signed informed consent by the patient or their family.
  • Exclusion Criteria:
  • Patients who fulfill any of the following conditions will be excluded a clear history of inducement, such as diseases caused by trauma, surgery, cognitive impairment, severe dysfunction of heart, liver, kidney and other organs, and malignant tumors, immune diseases and other malignant diseases.

About Hangzhou Medical College

Hangzhou Medical College is a leading academic institution dedicated to advancing healthcare through innovative research and education. Committed to fostering excellence in clinical trials, the college integrates cutting-edge scientific inquiry with a strong emphasis on ethical standards and patient safety. With a diverse team of experienced researchers and healthcare professionals, Hangzhou Medical College aims to contribute to the development of new therapies and improve clinical practices, ultimately enhancing patient outcomes and public health.

Locations

Hangzhou, Zhejiang, China

Patients applied

0 patients applied

Trial Officials

Xinyun Dr Li, doctor

Principal Investigator

hangzhou medical colleage

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported